Browsing by Author Picchio, G

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 8 to 11 of 11 < previous 
TitleAuthor(s)Issue DateViews
 
Reduction of hepatitis B surface antigen mediated by RNA interference therapeutic AB-729 in chronic hepatitis B patients is associated with T cell activation and a decline in exhausted CD8 T cells. Poster Presentation (SAT397)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Ganchua, SCParatala, BIott, CGane, EJYuen, RMFEley, TSims, KGray, KAntoniello, DLam, AMSofia, MJPicchio, GThi, EP
2022
1
 
Repeat dosing of the GalNAc-siRNA AB-729 in subjects with chronic hepatitis B results in robust and sustained HBsAg suppression
Proceeding/Conference:Journal of Hepatology
Yuen, RMFBerliba, ESukeepaisarnjaroen, WStrasser, STangkijvanich, PHolmes, JLeerapun, AJucov, AThi, EPWattamwar, TSofia, MJSevinsky, HGray, KAntoniello, DEley, TPicchio, GSims, KGane, E
2021
14
 
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B
Journal:Hepatology Communications
Yuen, MFBerliba, ESukeepaisarnjaroen, WAhn, SHTanwandee, TLim, YSKim, YJPoovorawan, KTangkijvanich, PSchwabe, CEley, TBrown, JLee, ACHThi, EPParatala, BMani, NSofia, MJPicchio, GSims, KDGane, EJ
4-Oct-2022
 
Safety, tolerability, pharmacokinetics (PK), and antiviral activity of the 3rd generation capsid inhibitor AB-836 in healthy subjects(HS) and subjects with chronic hepatitis B (CHB). Poster Presentation (SAT392)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Gane, EJJucov, AKolomiichuk, LEley, TBrown, JKing, YMedvedeva, EChernyakhovskyy, MMani, NCole, AGKultgen, SGPamulapati, RThi, EPHarasym, TODugyala, RChaudhari, SSofia, MJChild, MPicchio, GSims, KYuen, RMF
2022
Showing results 8 to 11 of 11 < previous